HORIEN secures Thai FDA Class 4 approvals and U.S. stent patent
HORIEN Biochemical Technology says it achieved three Thai FDA Class 4 approvals and secured a U.S. patent for a biodegradable ureteral stent, supporting a market-entry push via qualified Thai distributors.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.